1-2 of 2
Miguel Fernández Zarzoso
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Caplacizumab As New Paradigm-Changing Therapy for Patients with Autoimmune Thrombotic Thrombocytopenic Purpura (aTTP): Real-World Data from TTP Spanish Registry

Irene Garcia-Garcia, Moraima Jiménez, David Valcárcel, MD PhD, Maria Eva Mingot-Castellano, PhD MD, Maria Cristina Pascual Izquierdo, PhD MD, Aurora Viejo, MD, Miquel Lozano, Rosa Goterris, MD, Jorge Martínez Nieto, Ana Oliva, MD, Inés Gómez-Seguí, PhD, Luis Hernandez, MD, Saioa Zalba, Verónica Campuzano, Yolanda Martínez, Helena González, Inmaculada Tallon, Miguel Fernández Zarzoso, Gemma Moreno Jiménez, MD, Sunil Lakhwani Lakhwani, Sandra Ortega, María Solé, Jon Ander Atucha Fernández, Julio Del Rio-Garma, MD, Joan Cid, MDPhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 20–21.
https://doi.org/10.1182/blood-2020-136627
Published: 2020
Journal Articles

Phase II Trial to Evaluate the Efficacy and Safety of the Combination of Obinutuzumab and Bendamustine Treatment in Patients (Pts) with Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL)

Jose Garcia-Marco, MD PhD, Patricia Baltasar Tello, Esther González Garcia, Dra., Eduardo Ríos Herranz, MD, Angel Ramirez Payer, María José Terol Castera, Diana Champ, Angeles Medina Perez, Mercedes Gironella, Alicia Rodríguez Fernández, Ana Muntañola Prat, Alexia Suárez Cabrera, Manuel Jurado Chacón, Miguel Fernández Zarzoso, Mercedes Rodríguez, Juana Clavel, Maria Victoria Dourdil Sahun, Christelle M Ferra Coll, Ernesto Pérez Persona, Carmen Milagros Marrero Santos, Rafael Forés, Julio Delgado, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 4321.
https://doi.org/10.1182/blood.V130.Suppl_1.4321.4321
Published: 2017